What is Ivosidenib: Uses, Dosage, Side Effects and More

Ivosidenib is a targeted cancer medication that blocks specific proteins in cancer cells to help slow their growth. It's designed for people with certain blood cancers or bile duct cancers that have a particular genetic change called an IDH1 mutation.

This medication represents a more precise approach to cancer treatment, focusing on the specific genetic abnormalities that drive your cancer rather than attacking all rapidly dividing cells. Think of it as a key that fits into a very specific lock in cancer cells.

What is Ivosidenib?

Ivosidenib is an oral cancer medication that belongs to a class called IDH1 inhibitors. It works by targeting cancer cells that have a specific genetic mutation while leaving healthy cells largely unaffected.

The medication comes as tablets that you take by mouth, making treatment more convenient than traditional chemotherapy that requires hospital visits. Your doctor will prescribe this medication only after genetic testing confirms that your cancer has the IDH1 mutation.

This targeted approach means the medication can be more effective against your specific type of cancer while potentially causing fewer side effects than broader cancer treatments.

What is Ivosidenib Used For?

Ivosidenib treats two main types of cancer that have the IDH1 genetic mutation. Your doctor will use genetic testing to confirm you're a candidate for this treatment.

The medication is approved for acute myeloid leukemia (AML), a type of blood cancer that affects white blood cells. It's used when other treatments haven't worked or when you're not strong enough for intensive chemotherapy.

Ivosidenib also treats cholangiocarcinoma, which is cancer of the bile ducts. This rare cancer affects the tubes that carry bile from your liver to your small intestine.

In both cases, the medication specifically targets cancer cells with the IDH1 mutation, which occurs in about 6-10% of AML cases and 13-19% of bile duct cancers.

How Does Ivosidenib Work?

Ivosidenib blocks a mutated enzyme called IDH1 that cancer cells use to survive and multiply. This enzyme produces a substance that helps cancer cells avoid normal cell death.

By blocking this enzyme, the medication forces cancer cells to mature normally or die, rather than continuing to grow out of control. This process happens gradually over weeks to months.

The medication is considered moderately strong, meaning it's powerful enough to fight cancer but typically causes fewer severe side effects than traditional chemotherapy. Most people can continue their daily activities while taking it.

Your cancer cells need time to respond to this treatment, so you might not see improvements immediately. Your doctor will monitor your progress through regular blood tests and scans.

How Should I Take Ivosidenib?

Take ivosidenib exactly as your doctor prescribes, usually 500 mg once daily at the same time each day. You can take it with or without food, but try to be consistent with your routine.

Swallow the tablets whole with a glass of water. Don't crush, chew, or break them, as this can affect how the medication works in your body.

If you vomit within an hour of taking your dose, don't take another dose that day. Wait until your next scheduled dose the following day.

Try to take the medication at the same time each day to maintain steady levels in your bloodstream. Setting a daily alarm can help you remember.

You don't need to eat specific foods before taking ivosidenib, but maintaining good nutrition during cancer treatment supports your overall health and energy levels.

How Long Should I Take Ivosidenib For?

You'll typically take ivosidenib for as long as it's helping control your cancer and you're tolerating it well. This could be months to years, depending on how you respond.

Your doctor will monitor your progress through regular blood tests, usually every few weeks at first. These tests check both how well the medication is working and how your body is handling it.

Some people see improvements within the first few months, while others may need longer to respond. Your doctor will adjust your treatment plan based on your individual response.

Never stop taking ivosidenib suddenly without talking to your doctor first. Even if you feel better, the medication may still be working to control cancer cells you can't see or feel.

What Are the Side Effects of Ivosidenib?

Most people experience some side effects with ivosidenib, but they're often manageable with proper monitoring and care. The most common side effects affect your digestive system and energy levels.

Here are the side effects you're most likely to experience, along with what they might feel like:

• Fatigue and weakness that may make daily activities more tiring
• Nausea, which can range from mild queasiness to stronger stomach upset
• Diarrhea, typically mild but sometimes requiring dietary changes
• Decreased appetite, making food less appealing than usual
• Joint and muscle pain, similar to mild arthritis symptoms
• Cough, usually dry and not associated with infection

These common side effects often improve as your body adjusts to the medication over the first few weeks of treatment.

Less common but more serious side effects require immediate medical attention. While these don't happen to everyone, it's important to recognize them:

• Differentiation syndrome, causing fever, difficulty breathing, and fluid retention
• QT prolongation, affecting your heart rhythm
• Guillain-Barré syndrome, causing muscle weakness and numbness
• Severe infections due to low white blood cell counts
• Tumor lysis syndrome, occurring when cancer cells break down rapidly

Your healthcare team will monitor you closely for these rare but serious reactions through regular check-ups and lab work.

Who Should Not Take Ivosidenib?

Ivosidenib isn't right for everyone, even those with the IDH1 mutation. Your doctor will carefully review your medical history before prescribing this medication.

You shouldn't take ivosidenib if you're allergic to any of its ingredients or if you have severe heart rhythm problems that could worsen with treatment.

Pregnant women should not take this medication, as it can harm the developing baby. Women who could become pregnant need reliable birth control during treatment and for at least one month after stopping.

People with severe liver or kidney problems may need dose adjustments or alternative treatments. Your doctor will run tests to check these organs before starting treatment.

If you're taking certain medications that affect heart rhythm or interact with ivosidenib, your doctor may need to adjust your treatment plan or monitor you more closely.

Ivosidenib Brand Name

Ivosidenib is sold under the brand name Tibsovo. This is the only brand name currently available for this medication.

When you pick up your prescription, you'll see "Tibsovo" on the bottle label along with the generic name "ivosidenib." Both names refer to the same medication.

The medication comes as round, white tablets in different strengths, typically packaged in bottles with child-resistant caps for safety.

Ivosidenib Alternatives

Treatment alternatives depend on your specific type of cancer and overall health. For AML, alternatives might include other targeted therapies, chemotherapy, or stem cell transplant.

Enasidenib (Idhifa) is another IDH inhibitor, but it targets a different mutation called IDH2. Your doctor will only consider this if genetic testing shows you have the IDH2 mutation instead.

For bile duct cancer, alternatives might include standard chemotherapy combinations, immunotherapy, or other targeted therapies depending on your cancer's specific characteristics.

Your doctor will discuss all available options with you, considering factors like your age, overall health, previous treatments, and personal preferences.

Is Ivosidenib Better Than Other AML Treatments?

Ivosidenib offers advantages over traditional chemotherapy for people with IDH1-mutated cancers. It's generally easier to tolerate and allows many people to maintain better quality of life during treatment.

Unlike intensive chemotherapy, ivosidenib doesn't require hospitalization and has fewer severe side effects. This makes it particularly valuable for older adults or those with other health conditions.

However, "better" depends on your individual situation. Some people may need more aggressive treatment, while others benefit from ivosidenib's targeted approach.

Your doctor will help you weigh the benefits and risks of each treatment option based on your specific cancer characteristics, age, overall health, and treatment goals.